Literature DB >> 3982075

Results, complications, and follow-up of 415 bypass operations for occlusive disease of the carotid system.

T M Sundt, J P Whisnant, N C Fode, D G Piepgras, O W Houser.   

Abstract

Selected patients with acute or continuing ischemic symptoms from occlusions or inaccessible stenotic lesions of the internal carotid artery or middle cerebral artery have been considered candidates for a carotid artery-middle cerebral artery bypass procedure at our institution since July 1974. We report herein an 8-year experience through June 1982 with 415 operations in 403 patients in whom a branch of the superficial temporal artery was anastomosed to a branch of the middle cerebral artery. Patients selected for operation usually had had more than one form of ischemic symptom. The primary indication for operation was transient ischemic attacks, and the most common vascular pathologic condition was internal carotid artery occlusion. Preoperatively, 183 patients were taking antiplatelet agents and 157 were taking anticoagulants. Neurologic function 6 months postoperatively was equal to or better than the function preoperatively in 95% of survivors. The bypass pedicle was patent in 99% of patients studied. The mortality and morbidity associated with the surgical procedure varied on the basis of the patient's preoperative neurologic condition but were 1% and 4%, respectively, for the entire group at 30 days postoperatively. Of the 54 deaths during the entire follow-up period, 27 were cardiogenic and 6 were from ischemic stroke. On the basis of patient-months of follow-up, stroke was 8 times more likely to occur within 6 months after operation than thereafter.

Entities:  

Mesh:

Year:  1985        PMID: 3982075     DOI: 10.1016/s0025-6196(12)60315-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

Review 2.  Extracranial-intracranial bypass to reduce the risk of ischemic stroke.

Authors:  T V Holohan
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

3.  Revascularization of the posterior circulation.

Authors:  Bert A Coert; Steven D Chang; Michael P Marks; Gary K Steinberg
Journal:  Skull Base       Date:  2005-02

4.  Reactivity of the cerebral circulation in patients with carotid occlusion.

Authors:  M M Brown; J P Wade; C C Bishop; R W Russell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

5.  Postoperative evaluation of changes in extracranial-intracranial bypass graft using superficial temporal artery duplex ultrasonography.

Authors:  A Nakamizo; T Inoue; Y Kikkawa; K Uda; Y Hirata; K Okamura; M Yasaka; Y Okada
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

6.  Assessing success after cerebral revascularization for ischemia.

Authors:  John E Wanebo; Sepideh Amin-Hanjani; Cynthia Boyd; Terry Peery
Journal:  Skull Base       Date:  2005-08

Review 7.  Neurological improvement in chronic ischemic stroke following surgical brain revascularization.

Authors:  G F Rossi; G Maira; A Vignati; A Puca
Journal:  Ital J Neurol Sci       Date:  1987-10

8.  The masaryk hospital extracranial-intracranial bypass study.

Authors:  T Radovnicky; P Vachata; R Bartos; M Sames
Journal:  Neurosurg Rev       Date:  2016-05-18       Impact factor: 3.042

9.  Reversibility of cerebral ischaemia. Dynamic and xenon computed tomography study on ischaemic cerebrovascular disease.

Authors:  H Ujiie; A Oikawa; K Satoh; H Onda; M Kagawa; K Takakura; Y Kakinoki; Y Ono; N Kobayashi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Surgical results of the Carotid Occlusion Surgery Study.

Authors:  Robert L Grubb; William J Powers; William R Clarke; Tom O Videen; Harold P Adams; Colin P Derdeyn
Journal:  J Neurosurg       Date:  2012-10-26       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.